Successful stem cell transplantation for patients with severe combined immunodeficiency (SCID) from matched family donors without conditioning results in engraftment of T lymphocytes. B lymphocytes engraft in only 50% of the cases, while myelopoiesis and erythropoiesis remain of host origin. Full hematopoietic engraftment was reported in one case after bone marrow transplantation without conditioning for a SCID patient. We studied three SCID patients who were transplanted with unmodified mobilized peripheral blood from HLA-identical family sex-mismatched members. They received megadoses of stem cells (18-23 Â 10 6 CD34/kg). In contrast to the expected mixed chimerism that usually occurs in the absence of conditioning, we found in our patients 100% donor cell engraftment based on fluorescence in situ hybridization (FISH) and microsatellite techniques. Subset analysis of the engrafted cells using a multiparametric system enabling a combined analysis of morphology, immunophenotyping and FISH showed that both T and B lymphocytes and myeloid cells were of donor origin in two patients, while T lymphocytes and myeloid cells were of donor origin in the third. In the two cases with ABO incompatibility, erythroid engraftment was evidenced by blood group conversion from recipient to donor type. Multilineage donor engraftment is possible in SCID patients even without conditioning. Successful stem cell transplantation without conditioning in these patients results in T-lymphocyte engraftment and correction of the immune dysfunction. However, engraftment of B lymphocytes occurs in only 50% of the cases, NK cells are either donor or host in origin, whereas myelopoiesis and erythropoiesis remain of host origin.
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The preparative regimen ablates the host stem cells and enables the engraftment of donor stem cells which later differentiate to all cell lineages. In the absence of conditioning, the host stem cells are not ablated, and as donor stem cells do not have an advantage over host stem cells they usually do not engraft. Full donor hematopoietic engraftment after allogeneic bone marrow transplantation without conditioning has been reported in only one patient with adenosine deaminase (ADA)-deficient SCID. 3 Fluorescence in situ hybridization (FISH) using sexchromosome-specific probes is being increasingly used for the assessment of chimerism in sex-mismatched transplants. 4 However, this technology sometimes lacks both specificity and sensitivity. Flow-sorting of cell subsets provides sensitive assessment of changes in the pattern of chimerism which had escaped detection in assays using whole blood cell samples. 5 This technology, however, is laborious and requires high personnel skills. A simultaneous analysis of morphology, immunophenotyping and FISH of the same cell using a multiparametric cell-scanning system enables the detection of the cell origin of different cell subsets without the need of cell sorting. 6 We have followed the chimerism status of different cell subsets of three SCID patients after peripheral blood stem cell transplants from HLA identical sex-mismatched family members in the absence of conditioning over a period of 3.5-5.5 years. The chimerism status of whole blood samples was assessed by the traditional microsatellite and FISH assays, and chimerism of subsets was detected by the multiparametric cell-scanning system. We report the occurrence of multilineage engraftment in these patients.
Patients and Methods

Patients
Three patients with SCID: two with recombinase activating gene (RAG) mutations and one with adenosine deaminase (ADA) deficiency are described. Patients' characteristics pre-transplant are shown in Table 1 . Patients received unmanipulated mobilized peripheral blood stem cells without pre-transplant conditioning. Transplantation data are presented in Table 2 . The donors were an HLA-identical parent in one case and HLA-identical siblings 8 and 14 years of age in the other two cases. All donors were sexmismatched with the recipient. All donors were CMV positive. Patient 1 was also CMV positive, while patients 2 and 3 were too young to determine a reliable CMV status. No GVHD prophylaxis was given.
Immune reconstitution was assessed by immunophenotyping of peripheral blood lymphocytes and the proliferative response to mitogens at 3 months to 3 years post transplant.
Specimen processing and analysis
The Duett System (Bioview Ltd, Rehovot, Israel) provides combined analysis of the cells by morphology or immunophenotyping and FISH. Up to three parameters can be tested on the same cell. The system allows rapid automatic scanning of a large number of cells for identification of small cell populations by their morphology or cytogenetic characteristics. Slides are prepared from a peripheral blood sample by density gradient centrifugation and cytospin. The slides are air-dried and stained with May-GrunwaldGiemsa (MGG) (Sigma, St Louis) or with immunostaining. The stained slides are automatically scanned by the hematological workstation and the coordinates and images of all cells are saved for future reference during the next phases of the analysis. At least 100 000 cells were scanned in each case.
Immunostaining and fluorescence in situ hybridization (FISH)
Slides were labeled with two different antibodies (CD3 for the detection of T cells and CD19 or CD20 for the detection of B cells) using the Envison Doublestain System (DAKO). Staining procedure was performed according to the protocol supplied by the manufacturer with minor modifications. Slides were fixed in ice-cold acetone for 3 min, followed by a wash in TBS at room temperature. Slides were blocked in 10% goat serum/PBS for 30 min at room temperature. The two antibodies were sequentially applied to the slides and stained by two different chromogens. The CD19 or CD20 antibodies were detected using a peroxidase-labeled secondary antibody and stained with DAB (brown staining). The CD3 antibody was detected using an alkaline-labeled secondary antibody and stained with Fast Red (red staining).
FISH was performed after removal of the MGG or the immunostaining as described previously. 7 Chromosome Y satellite III sequence probe (SpectrumGreen; Vysis, Downers Grove, IL, USA) and a chromosome X centromeric sequence probe (SpectrumOrange; Vysis) were used for hybridization to differentiate between donor and recipient derived cells. Figure 1 .
Results
All
Combined morphologic and FISH analysis of the cells revealed that all cell subsets (neutrophils, lymphocytes and monocytes) were of donor origin in all three patients (Figure 2 ). Further evaluation using anti-CD3 and anti-CD19 or anti-CD20 monoclonal antibodies showed that both lymphocyte subsets were of donor origin in patients 2 and 3, while no B cells were detected in patient 1. The results were confirmed by FACS analysis.
Evidence of donor origin erythropoiesis was confirmed by conversion of the recipient blood type from O þ to A þ in patient 2 and conversion from blood type B þ to AB þ in patient 3. Patient 1 and his donor shared the same blood type.
All patients developed acute GVHD. Patient 1 had an abrupt decrease in his neutrophil count 18 days post Table 1 Patients' characteristics pre stem-cell transplantation transplantation, impaired liver function tests and hyperbilirubinemia, consistent with acute GVHD. This was followed by a gradual increase in donor cell chimerism, concomitant with an elevation of the neutrophils count as demonstrated in Figure 3 . He was successfully treated with steroids and cyclosporine. Patient 2 developed acute GVHD 2 weeks post transplant, which involved the skin and gastrointestinal tract, and was treated with steroids with prompt resolution of the symptoms. Patient 3 developed acute GVHD 3 weeks post transplant, which involved the skin and gastrointestinal tract and was treated with steroids and gradually improved. 
Discussion
In contrast to the well-established concept of donor T-cell engraftment and the persistence of host hematopoiesis, we have shown that our three SCID patients had complete donor myeloid engraftment and two of them also had evidence of donor erythropoiesis. This subject has only been rarely studied by other investigators.
Haddad et al 1 showed that donor monocyte engraftment occurred in only a minority of B þ SCID patients after BMT without conditioning. Evidence of donor-type multipotent CD34 cells engraftment (although of a very low number) has been demonstrated in a patient with B-SCID. Despite the presence of donor stem cells, there was no evidence of donor B lymphopoiesis and myelopoiesis, with no apparent explanation. 8 To date, there is only one reported case of full hematopoietic engraftment after BMT without cytoreduction in a child with SCID. 3 One possible explanation for the multilineage engraftment is that the development of GVHD led to destruction of the host hematopoietic stem cells by donor T cells. This paved the way to multilineage donor engraftment. As peripheral blood contains many more T cells than BM, this phenomenon is expected to be more prevalent when this source of stem cells is used. Our three patients developed acute GVHD, which included severe neutropenia in patient 1 on day 18 post transplant, followed by an increase in the percentage of donor cells as demonstrated by microsatellite analysis (Figure 3 ). This could enable the engraftment of donor stem cells which later differentiated to the different cell lineages.
The second explanation could arise from the use of mobilized peripheral blood as the source of the graft. A unique feature of peripheral blood is the ability to infuse a much higher number of stem cells as compared to bone marrow.
The concept of 'megadose' stem cells was studied in the past in the setting of haploidentical mismatched transplants. Infusion of large doses of purified peripheral blood CD34 cells overcomes major histocompatibility barriers and enables engraftment. It was also demonstrated that the CD34 cells possess a potent 'veto' activity and thus can overcome resistance to engraftment by recipient cytotoxic T lymphocytes. 9 It is possible that the high numbers of donor stem cells provide them with an advantage in competition with the host cells (even without a preparative regimen), leading to complete donor engraftment. We evaluated three other SCID patients (one with RAG mutation and two with an unclassified SCID), who were transplanted from HLA identical donors in our unit from peripheral blood in the same time period. They showed a pattern of mixed chimerism with T-cell engraftment only. The average dose of CD34 cells that they received was 10 Â 10 6 /kg (data not shown), which is half the number which was infused in the three patients described here. No differences were found in the number of the infused T cells between the two groups of patients. These data provide additional support for the role of the CD34 þ cell dose in the establishment of multilineage engraftment in the absence of conditioning.
The absence of B lymphocytes in patient 1, despite donor T lymphopoiesis and myelopoiesis indicates that unknown factors prevent differentiation and maturation along the B-cell lineage. Tjonnfjord et al 8 also showed that, although CD34 þ cells coexpressing B lymphocyte antigens engrafted, there was no B-lymphocyte reconstitution. To date, the precise mechanism of B cell engraftment in SCID patients is still obscure. It could be that factors related to the specific SCID phenotype like intrinsic B-cell defects or the presence of NK cells have an important role in this process. The importance of NK cells in the process of engraftment, not particularly of B cells, was previously suggested by Bertrand et al. 10 Of interest, patient 1 in our study had a relatively high number of NK cells and no engraftment of B cells. In summary, multilineage engraftment is possible in SCID patients even without conditioning regimen. Whether this resulted from the abundant number of stem cells or the presence of GVHD is a matter for further studies.
In the past, the major source of stem cells was BM. With the emerging use of peripheral blood as the source of stem cells, we may see more cases of full donor engraftment in the absence of conditioning.
